High Value Medications Project
PROJECT BACKGROUND AND ELIGIBILITY INFORMATION
Medpin worked with a statewide group of "safety net" health care professionals and academic pharmacy experts to select the drugs that will receive direct project support. (For more information on the California Safety Net Alliance for Pharmacy & Therapeutics Support, see CalSNAPTS)
PHARMACEUTICAL PRODUCTS CHOSEN IN TWO CATEGORIES:
- HIGH CHOLESTEROL: All three statin drugs available generically.
STATINS: lovastatin, pravastatin, and simvastatin. All available strengths
- DIABETES: Some drugs and patient health monitoring supplies.
METFORMIN: Immediate or sustained release. Including, Glipizide/Metformin & Glyburide/Metformin. All available strengths.
BLOOD GLUCOSE TEST AGENTS: Strips or other. Any supplier.
Both nonprofit and public agency outpatient clinics are participating in the High Value Medications Project. Participating clinics have also documented compliance with pharmacy licensing laws.
REIMBURSEMENT FOR ELIGIBLE DRUG PURCHASES
Each participating clinic submits invoice information, then is reimbursed for qualified expenditures. Each clinic may receive total reimbursement up to a credit limit assigned by Medpin based on that clinic's care of indigent and uninsured patients.
ADDITIONAL PROJECT BENEFITS
All California community clinics and county health system providers, whether or not they receive Project reimbursement, are invited to use materials specially developed for this project. These support prescribing and health outcome measurement connected with management of diabetes and cardiac disease in low-income patients. Medpin is developing and distributing these to any interested safety net providers.
back to top